RIGL logo

Rigel Pharmaceuticals (RIGL) Non Current Assets

Annual Non Current Assets

$17.96 M
-$417.00 K-2.27%

December 31, 2023

Summary

Performance

1-Year Change

-2.27%

3-Year Change

-16.06%

5-Year Change

+746.32%

15-Year Change

+970.26%

RIGL Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.06%
RIGL annual long term assets is higher than 48.06% of companies in Healthcare sector

High & Low

All-time High

$28.56 M
RIGL annual long term assets is currently -37.13% below its historical high of $28.56 million

3-Year Low

$12.86 M
RIGL annual long term assets is currently +39.64% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RIGL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
RIGL next annual earnings announcement is scheduled for Mar 5, 2025

OtherRIGLbalance sheetmetrics:

Annual Total Assets

$117.22 M
RIGL annual total assets is $117.22 million

Annual Current Assets

$99.27 M
RIGL annual total current assets is $99.27 million

Annual Total Liabilities

$145.87 M
RIGL annual total liabilities is $145.87 million

Annual Total Long Term Liabilities

$92.60 M
RIGL annual total long term liabilities is $92.60 million

Quarterly Non Current Assets

$32.95 M
-$733.00 K-2.18%

September 30, 2024

Summary

Performance

3-Month Change

-2.18%

1-Year Change

+62.33%

3-Year Change

+156.22%

5-Year Change

+9.62%

RIGL Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.51%
RIGL quarterly long term assets is higher than 55.51% of companies in Healthcare sector

High & Low

All-time High

$34.03 M
RIGL quarterly long term assets is currently -3.18% below its historical high of $34.03 million

3-Year Low

$5.17 M
RIGL quarterly long term assets is currently +537.49% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RIGL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
RIGL next earnings announcement is scheduled for Mar 5, 2025

OtherRIGLbalance sheetmetrics:

Quarterly Total Assets

$139.42 M
RIGL quarterly total assets is $139.42 million

Quarterly Current Assets

$106.47 M
RIGL quarterly total current assets is $106.47 million

Quarterly Total Liabilities

$154.06 M
RIGL quarterly total liabilities is $154.06 million

Quarterly Long Term Liabilities

$99.74 M
RIGL quarterly total long term liabilities is $99.74 million

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

RIGL Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.3%+62.3%
3 y3 years-16.1%+156.2%
5 y5 years+746.3%+9.6%

RIGL Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.3%+39.6%-3.2%+537.5%
5 y5-year-37.1%+39.6%-3.2%+537.5%
alltimeall time-37.1%+970.3%-3.2%+1863.8%

Rigel Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$32.95 M(-2.2%)
Jun 2024
-
$33.69 M(-1.0%)
Mar 2024
-
$34.03 M(+89.5%)
Dec 2023
$99.27 M(-14.4%)
$17.96 M(-11.5%)
Sep 2023
-
$20.30 M(+25.6%)
Jun 2023
-
$16.17 M(-2.8%)
Mar 2023
-
$16.64 M(-9.4%)
Dec 2022
$115.90 M(-25.0%)
$18.38 M(+255.5%)
Sep 2022
-
$5.17 M(-30.9%)
Jun 2022
-
$7.48 M(-26.2%)
Mar 2022
-
$10.14 M(-21.2%)
Dec 2021
$154.47 M(+73.6%)
$12.86 M(-16.6%)
Sep 2021
-
$15.41 M(-11.4%)
Jun 2021
-
$17.40 M(-9.5%)
Mar 2021
-
$19.23 M(-10.1%)
Dec 2020
$88.98 M(-25.2%)
$21.39 M(-7.8%)
Sep 2020
-
$23.21 M(-7.0%)
Jun 2020
-
$24.95 M(-7.7%)
Mar 2020
-
$27.03 M(-5.4%)
Dec 2019
$119.00 M(-13.1%)
$28.56 M(-5.0%)
Sep 2019
-
$30.06 M(-5.0%)
Jun 2019
-
$31.65 M(-5.4%)
Mar 2019
-
$33.47 M(+1477.0%)
Dec 2018
$136.99 M(+16.7%)
$2.12 M(-0.5%)
Sep 2018
-
$2.13 M(-1.3%)
Jun 2018
-
$2.16 M(-1.4%)
Mar 2018
-
$2.19 M(+30.7%)
Dec 2017
$117.43 M(+54.1%)
$1.68 M(-0.7%)
Sep 2017
-
$1.69 M(+0.2%)
Jun 2017
-
$1.69 M(-6.4%)
Mar 2017
-
$1.80 M(-6.1%)
Dec 2016
$76.21 M(-40.9%)
$1.92 M(-8.3%)
Sep 2016
-
$2.09 M(-13.6%)
Jun 2016
-
$2.42 M(-9.4%)
Mar 2016
-
$2.67 M(-1.8%)
Dec 2015
$129.02 M(-14.3%)
$2.72 M(-8.9%)
Sep 2015
-
$2.99 M(+5.6%)
Jun 2015
-
$2.83 M(-10.6%)
Mar 2015
-
$3.17 M(-12.0%)
Dec 2014
$150.54 M(-31.6%)
$3.60 M(-15.9%)
Sep 2014
-
$4.28 M(-12.6%)
Jun 2014
-
$4.89 M(-10.5%)
Mar 2014
-
$5.46 M(-8.7%)
Dec 2013
$220.07 M(-27.2%)
$5.98 M(-8.3%)
Sep 2013
-
$6.52 M(-8.1%)
Jun 2013
-
$7.10 M(-5.8%)
Mar 2013
-
$7.53 M(-0.7%)
Dec 2012
$302.46 M
$7.58 M(-1.3%)
DateAnnualQuarterly
Sep 2012
-
$7.69 M(-3.8%)
Jun 2012
-
$7.99 M(+1.9%)
Mar 2012
-
$7.84 M(+14.0%)
Dec 2011
$250.23 M(+39.1%)
$6.87 M(-5.5%)
Sep 2011
-
$7.27 M(-0.3%)
Jun 2011
-
$7.30 M(+0.8%)
Mar 2011
-
$7.24 M(+6.9%)
Dec 2010
$179.93 M(+32.3%)
$6.77 M(+16.7%)
Jun 2010
-
$5.80 M(+19.5%)
Mar 2010
-
$4.85 M(+1.6%)
Dec 2009
$135.97 M(-1.5%)
$4.78 M(-7.3%)
Sep 2009
-
$5.15 M(-8.7%)
Jun 2009
-
$5.64 M(-6.4%)
Mar 2009
-
$6.03 M(+4.5%)
Dec 2008
$138.09 M(+24.3%)
$5.77 M(+11.4%)
Sep 2008
-
$5.18 M(+1.5%)
Jun 2008
-
$5.11 M(+11.6%)
Mar 2008
-
$4.58 M(-1.8%)
Dec 2007
$111.13 M(+2.9%)
$4.66 M(-6.2%)
Sep 2007
-
$4.97 M(-3.0%)
Jun 2007
-
$5.12 M(-3.5%)
Mar 2007
-
$5.31 M(+1.6%)
Dec 2006
$108.01 M(-24.3%)
$5.23 M(-4.1%)
Sep 2006
-
$5.45 M(+11.3%)
Jun 2006
-
$4.90 M(-3.3%)
Mar 2006
-
$5.07 M(-0.1%)
Dec 2005
$142.60 M(+92.1%)
$5.07 M(+17.4%)
Sep 2005
-
$4.32 M(-3.3%)
Jun 2005
-
$4.47 M(-5.2%)
Mar 2005
-
$4.71 M(+2.8%)
Dec 2004
$74.24 M(+48.1%)
$4.58 M(+0.6%)
Sep 2004
-
$4.55 M(+1.2%)
Jun 2004
-
$4.50 M(-6.9%)
Mar 2004
-
$4.83 M(-10.7%)
Dec 2003
$50.11 M(+35.9%)
$5.41 M(-10.2%)
Sep 2003
-
$6.03 M(-9.4%)
Jun 2003
-
$6.65 M(-4.9%)
Mar 2003
-
$7.00 M(-6.5%)
Dec 2002
$36.86 M(+0.9%)
$7.48 M(-48.3%)
Sep 2002
-
$14.48 M(+29.3%)
Jun 2002
-
$11.19 M(+6.7%)
Mar 2002
-
$10.49 M(+5.8%)
Dec 2001
$36.53 M(-33.2%)
$9.91 M(-5.6%)
Sep 2001
-
$10.51 M(-4.9%)
Jun 2001
-
$11.05 M(+9.7%)
Mar 2001
-
$10.08 M(+5.2%)
Dec 2000
$54.68 M(+541.1%)
$9.58 M
Dec 1999
$8.53 M
-

FAQ

  • What is Rigel Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Rigel Pharmaceuticals?
  • What is Rigel Pharmaceuticals annual non current assets year-on-year change?
  • What is Rigel Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Rigel Pharmaceuticals?
  • What is Rigel Pharmaceuticals quarterly non current assets year-on-year change?

What is Rigel Pharmaceuticals annual long term assets?

The current annual non current assets of RIGL is $17.96 M

What is the all time high annual non current assets for Rigel Pharmaceuticals?

Rigel Pharmaceuticals all-time high annual long term assets is $28.56 M

What is Rigel Pharmaceuticals annual non current assets year-on-year change?

Over the past year, RIGL annual long term assets has changed by -$417.00 K (-2.27%)

What is Rigel Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of RIGL is $32.95 M

What is the all time high quarterly non current assets for Rigel Pharmaceuticals?

Rigel Pharmaceuticals all-time high quarterly long term assets is $34.03 M

What is Rigel Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, RIGL quarterly long term assets has changed by +$12.65 M (+62.33%)